Special items: Ovarian Cancer and Us blog best viewed in Firefox

Wednesday, January 19, 2011

(Avastin)Bevacizumab in Breast Cancer: Genentech Submits Response to FDA


No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.